Machine learning-based prognostic prediction and surgical guidance for intrahepatic cholangiocarcinoma.

Journal: Bioscience trends
PMID:

Abstract

The prognosis following radical surgery for intrahepatic cholangiocarcinoma (ICC) is poor, and optimal follow-up strategies remain unclear, with ongoing debates regarding anatomic resection (AR) versus non-anatomic resection (NAR). This study included 680 patients from five hospitals, comparing a combination of eight feature screening methods and 11 machine learning algorithms to predict prognosis and construct integrated models. These models were assessed using nested cross-validation and various datasets, benchmarked against TNM stage and performance status. Evaluation metrics such as area under the curve (AUC) were applied. Prognostic models incorporating screened features showed superior performance compared to unselected models, with AR emerging as a key variable. Treatment recommendation models for surgical approaches, including DeepSurv, neural network multitask logistic regression (N-MTLR), and Kernel support vector machine (SVM), indicated that N-MTLR's recommendations were associated with survival benefits. Additionally, some patients identified as suitable for NAR were within groups previously considered for AR. In conclusion, three robust clinical models were developed to predict ICC prognosis and optimize surgical decisions, improving patient outcomes and supporting shared decision-making for patients and surgeons.

Authors

  • Long Huang
    a Institute of Functional Molecules, College of Chemistry and Life Science , Chengdu Normal University , Chengdu , China.
  • Jianbo Li
    Department of Forensic Medicine, Faculty of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China. Electronic address: 100390@cqmu.edu.cn.
  • Shuncang Zhu
    Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
  • Liang Wang
    Information Department, Dazhou Central Hospital, Dazhou 635000, China.
  • Ge Li
    Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510100, China.
  • Junyong Pan
    Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Fujian Medical University, Quanzhou, Fujian, China.
  • Chun Zhang
    Department of Ophthalmology, Peking University Third Hospital, Beijing, China.
  • Jianlin Lai
    Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
  • Yifeng Tian
    Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
  • Shi Chen
    Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, PUMCH, CAMS & PUMC, Beijing, China.